Total Payments
$7,365
2024 Payments
$2,938
Companies
35
Transactions
171
Medicare Patients
997
Medicare Billing
$60,955
Payment Breakdown by Category
Food & Beverage$7,265 (98.6%)
Education$99.99 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,265 | 170 | 98.6% |
| Education | $99.99 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,454 | 16 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $558.09 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $557.30 | 6 | $0 (2024) |
| ABBVIE INC. | $540.15 | 17 | $0 (2024) |
| PFIZER INC. | $424.49 | 36 | $0 (2024) |
| Galderma Laboratories, L.P. | $328.50 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $326.66 | 4 | $0 (2024) |
| Amgen Inc. | $316.50 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $297.27 | 8 | $0 (2023) |
| UCB, Inc. | $250.17 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,938 | 42 | Janssen Biotech, Inc. ($553.74) |
| 2023 | $2,179 | 34 | Janssen Biotech, Inc. ($867.60) |
| 2022 | $700.05 | 13 | Janssen Scientific Affairs, LLC ($248.16) |
| 2021 | $29.39 | 2 | AbbVie Inc. ($16.46) |
| 2020 | $48.33 | 2 | SI-BONE, Inc. ($48.33) |
| 2019 | $411.70 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($106.13) |
| 2018 | $727.56 | 51 | PFIZER INC. ($221.92) |
| 2017 | $331.00 | 15 | Merck Sharp & Dohme Corporation ($118.75) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 7 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 02/08/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/06/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: VACCINE | ||||||
| 02/05/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/22/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 01/09/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Endocrinology | ||||||
| 09/19/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 09/18/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Diabetes | ||||||
| 07/20/2017 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $63.24 | General |
| Category: BioOncology | ||||||
| 06/28/2017 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Diabetes | ||||||
| 06/15/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: OUD | ||||||
| 05/23/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $53.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/17/2017 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $40.05 | General |
| Category: WOMENS HEALTH | ||||||
| 05/03/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Diabetes | ||||||
| 04/24/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: CNS | ||||||
| 04/20/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2017 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Immunology | ||||||
| 01/30/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $9.74 | General |
| 01/11/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.49 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 202 | 371 | $21,034 | $9,501 |
| 2021 | 7 | 440 | 828 | $54,325 | $32,074 |
| 2020 | 6 | 355 | 569 | $41,059 | $19,380 |
Total Patients
997
Total Services
1,768
Medicare Billing
$60,955
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 57 | 70 | $5,527 | $2,699 | 48.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 22 | 24 | $2,841 | $1,638 | 57.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 29 | $3,567 | $1,396 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 33 | $2,616 | $1,324 | 50.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 23 | 34 | $2,666 | $1,017 | 38.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2022 | 23 | 25 | $2,212 | $897.36 | 40.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 12 | 12 | $586.82 | $343.13 | 58.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2022 | 19 | 144 | $1,018 | $186.39 | 18.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 153 | 210 | $14,109 | $10,183 | 72.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 65 | 91 | $10,208 | $6,785 | 66.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 102 | $12,144 | $5,903 | 48.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 64 | $4,521 | $2,982 | 66.0% |
| 17110 | Destruction of up to 14 skin growths | Facility | 2021 | 44 | 60 | $5,187 | $2,623 | 50.6% |
| 17000 | Destruction of skin growth | Facility | 2021 | 28 | 50 | $3,463 | $1,708 | 49.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 11 | 17 | $1,997 | $737.99 | 37.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 21 | 21 | $742.60 | $517.18 | 69.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 11 | 14 | $561.40 | $330.72 | 58.9% |
| 17003 | Destruction of 2-14 skin growths | Facility | 2021 | 23 | 199 | $1,392 | $302.94 | 21.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 119 | 166 | $10,904 | $6,366 | 58.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 60 | $8,860 | $3,614 | 40.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 61 | 69 | $6,729 | $3,585 | 53.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 61 | $7,271 | $2,099 | 28.9% |
| 17110 | Destruction of up to 14 skin growths | Facility | 2020 | 24 | 36 | $3,060 | $1,727 | 56.4% |
| 17000 | Destruction of skin growth | Facility | 2020 | 17 | 28 | $1,904 | $971.33 | 51.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 40 | 46 | $1,610 | $848.16 | 52.7% |
About Dr. Amit Sharma, DO
Dr. Amit Sharma, DO is a Family Medicine healthcare provider based in Hialeah, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2014. The National Provider Identifier (NPI) number assigned to this provider is 1295149102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Sharma, DO has received a total of $7,365 in payments from pharmaceutical and medical device companies, with $2,938 received in 2024. These payments were reported across 171 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,265).
As a Medicare-enrolled provider, Sharma has provided services to 997 Medicare beneficiaries, totaling 1,768 services with total Medicare billing of $60,955. Data is available for 3 years (2020–2022), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties General Acute Care Hospital, General Acute Care Hospital
- Location Hialeah, FL
- Active Since 06/18/2014
- Last Updated 10/11/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295149102
Products in Payments
- TREMFYA (Drug) $1,781
- Sotyktu (Drug) $546.49
- DUPIXENT (Biological) $324.69
- ILUMYA (Biological) $278.38
- Bimzelx (Biological) $218.98
- OPZELURA (Drug) $185.76
- RINVOQ (Biological) $172.50
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $165.15
- SKYRIZI (Biological) $162.04
- VRAYLAR (Drug) $151.14
- TWYNEO (Drug) $146.54
- CIBINQO (Drug) $146.41
- Winlevi (Drug) $136.82
- FARXIGA (Drug) $122.61
- VTAMA (Drug) $118.18
- Otezla (Drug) $116.84
- COSENTYX (Biological) $116.08
- JUBLIA (Drug) $111.74
- VYJUVEK (Drug) $100.69
- NEXPLANON (Drug) $89.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hialeah
Dr. Jose Orcasita-Ng, M.d, M.D
Family Medicine — Payments: $51,855
Family Medicine $51,855
Rafael Abreu, M.d, M.D
Family Medicine — Payments: $24,889
Family Medicine $24,889
Dr. Jorge Travieso, Md, MD
Family Medicine — Payments: $8,296
Family Medicine $8,296
Dr. Blanca Gonzalez, M.d, M.D
Family Medicine — Payments: $7,547
Family Medicine $7,547
Wayne Case, Md, MD
Family Medicine — Payments: $7,438
Family Medicine $7,438
Dr. Pedro Alvarez, Do, DO
Family Medicine — Payments: $7,251
Family Medicine $7,251